Indefinite Delivery Contract SPE2DR25D1052

The federal contract IDV award SPE2DR25D1052 is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $9,999,999,999 and a period of performance through December 31, 2036. This IDC serves as a primary vehicle for DLA to procure essential medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas to support military healthcare programs globally.

The original solicitation, issued by the DLA Troop Support Medical Supply Chain, aims to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple suppliers to provide worldwide pharmaceutical support to various DoD customers. The contracts will have a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. Awards will be made on a regional basis, with at least three different contractors selected across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items. Both primary and backup suppliers will provide separate distribution fees for brand/generic and specialty pharmaceuticals to support normal and contingency operations.